Literature DB >> 15684329

Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane.

Peter S Amenta1, Nicole A Scivoletti, Marissa D Newman, Justin P Sciancalepore, Deqin Li, Jeanne C Myers.   

Abstract

Type XV is a large collagen-proteoglycan found in all human tissues examined. By light microscopy it was localized to most epithelial and all nerve, muscle, fat and endothelial basement membrane zones except for the glomerular capillaries or hepatic/splenic sinusoids. This widespread distribution suggested that type XV may be a discrete structural component that acts to adhere basement membrane to the underlying connective tissue. To address these issues, immunogold ultrastructural analysis of type XV collagen in human kidney, placenta, and colon was conducted. Surprisingly, type XV was found almost exclusively associated with the fibrillar collagen network in very close proximity to the basement membrane. Type XV exhibited a focal appearance directly on the surface of, or extending from, the fibers in a linear or clustered array. The most common single arrangement was a bridge of type XV gold particles linking thick-banded fibers. The function of type XV in this restricted microenvironment is expected to have an intrinsic dependence upon its modification with glycosaminoglycan chains. Present biochemical characterization showed that the type XV core protein in vivo carries chains of chondroitin/dermatan sulfate alone, or chondroitin/dermatan sulfate together with heparan sulfate in a differential ratio. Thus, type XV collagen may serve as a structural organizer to maintain a porous meshwork subjacent to the basement membrane, and in this domain may play a key role in signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684329     DOI: 10.1369/jhc.4A6376.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  20 in total

1.  Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.

Authors:  Angel M Cuesta; David Sánchez-Martín; Ana Blanco-Toribio; Maider Villate; Kelly Enciso-Álvarez; Ana Alvarez-Cienfuegos; Noelia Sainz-Pastor; Laura Sanz; Francisco J Blanco; Luis Alvarez-Vallina
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Tumor suppression by collagen XV is independent of the restin domain.

Authors:  Michael J Mutolo; Kirsten J Morris; Shih-Hsing Leir; Thomas C Caffrey; Marzena A Lewandowska; Michael A Hollingsworth; Ann Harris
Journal:  Matrix Biol       Date:  2012-04-16       Impact factor: 11.583

3.  Complete suppression of tumor formation by high levels of basement membrane collagen.

Authors:  Ann Harris; Henry Harris; Michael A Hollingsworth
Journal:  Mol Cancer Res       Date:  2007-12       Impact factor: 5.852

4.  Recombinant human collagen XV regulates cell adhesion and migration.

Authors:  Merja Hurskainen; Florence Ruggiero; Pasi Hägg; Taina Pihlajaniemi; Pirkko Huhtala
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

Review 5.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 6.  The collagen family.

Authors:  Sylvie Ricard-Blum
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

7.  Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.

Authors:  Brittany G Durgin; Olga A Cherepanova; Delphine Gomez; Themistoclis Karaoli; Gabriel F Alencar; Joshua T Butcher; Yu-Qing Zhou; Michelle P Bendeck; Brant E Isakson; Gary K Owens; Jessica J Connelly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-10       Impact factor: 4.733

8.  Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.

Authors:  Jenean H O'Brien; Lauren A Vanderlinden; Pepper J Schedin; Kirk C Hansen
Journal:  J Proteome Res       Date:  2012-08-30       Impact factor: 4.466

Review 9.  Collagen XV: exploring its structure and role within the tumor microenvironment.

Authors:  Anthony George Clementz; Ann Harris
Journal:  Mol Cancer Res       Date:  2013-09-16       Impact factor: 5.852

Review 10.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.